Evidence map›Paper›PMID 40264781›Full record

ArticleFrontiers in immunology2025

Insufficient CXCL13 secretion in leprosy foamy macrophages attenuates lymphocyte recruitment and antimicrobial protein production.

Chuan Wang, Yuan Zhang, Tingting Liu, Zihao Mi, Peidian Shi, Zhenzhen Wang, Wenchao Li, Honglei Wang, Hong Liu, Furen Zhang

Abstract read
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Chuan Wang *Hospital for Skin Diseases, Shandong First Medical University, Jinan, Shandong, China.
Yuan Zhang *Hospital for Skin Diseases, Shandong First Medical University, Jinan, Shandong, China.
Tingting LiuHospital for Skin Diseases, Shandong First Medical University, Jinan, Shandong, China.
Zihao MiHospital for Skin Diseases, Shandong First Medical University, Jinan, Shandong, China.
Peidian ShiHospital for Skin Diseases, Shandong First Medical University, Jinan, Shandong, China.
Zhenzhen WangHospital for Skin Diseases, Shandong First Medical University, Jinan, Shandong, China.
Wenchao LiHospital for Skin Diseases, Shandong First Medical University, Jinan, Shandong, China.
Honglei WangHospital for Skin Diseases, Shandong First Medical University, Jinan, Shandong, China.
Hong LiuHospital for Skin Diseases, Shandong First Medical University, Jinan, Shandong, China.
Furen ZhangHospital for Skin Diseases, Shandong First Medical University, Jinan, Shandong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Pathogens trigger metabolic reprogramming, leading to the formation of foamy macrophages (FMs). This process provides a favorable environment for bacterial proliferation and enables bacteria to evade immune killing. Objective: To elucidate the mechanisms by which pathogens escape immune surveillance and elimination via the formation of FMs. Methods: We constructed a FM model using monocyte-derived macrophages (MDMs) that were incubated with oxidized low-density lipoprotein (oxLDL). Subsequently, we employed bulk RNA-sequencing (bulk RNA-seq) to comprehensively analyze the immune responses in MDMs and FMs against Results: We found that CXCL13, a component of the cytokine-cytokine receptor interaction pathway, was specifically upregulated in Conclusion: In conclusion, the NLRP12/NF-κB/CXCL13 axis is crucial for the immune response of FMs after mycobacterial infection. These findings contribute to a deeper understanding of the pathological mechanisms of mycobacterial infection.

Indexed as

Antimicrobial PeptidesChemokine CXCL13LeprosyLymphocytesMacrophagesMycobacterium lepraeCells, CulturedHumansLipoproteins, LDLMaleSignal TransductionAntimicrobial PeptidesChemokine CXCL13CXCL13 protein, humanLipoproteins, LDLoxidized low density lipoproteinantimicrobial proteinsCXCL13foamy macrophagemycobacterial infectionNLRP12

Identifiers

PMID40264781
PMCPMC12011874

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.